Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown

dc.contributor.authorSiemens, Jo-Marie A.
dc.contributor.authorBhoora, Urvisha
dc.contributor.authorJanse van Rensburg, Michelle Nedine Schorn
dc.date.accessioned2024-02-16T11:06:41Z
dc.date.available2024-02-16T11:06:41Z
dc.date.issued2023-09-05
dc.descriptionDATA AVAILABILITY : Data supporting the findings of this study are available from the corresponding author, J.-M.A.S., on request.en_US
dc.description.abstractBACKGROUND : Temporary shelters were established for street-based people during the national level 5 coronavirus disease 2019 (COVID-19) lockdown. However, street-based substance users’ need to access substances was not addressed, resulting in large numbers of people experiencing withdrawal. The Community Oriented Substance Use Programme (COSUP) in Tshwane provided methadone to manage opioid withdrawal. METHODS : A cross-sectional, descriptive study was conducted using the daily methadone dosing records from shelters in Tshwane between March 2020 and September 2020. RESULTS : The final analysis included 495 participants, of which 64 (12.9%) were initiated on 20 mg – 30 mg of methadone, 397 (80.2%) on 40 mg – 50 mg, and 34 (6.9%) on 60 mg – 70 mg. A total of 194 (39.2%) participants continued their initiation dose for 1–2 months, after which 126 (64.9%) had their doses increased, and 68 (35.1%) had their doses decreased. Approximately 12 (2.4%) participants were weaned off methadone after 1–3 months and 46 (9.3%) after 4–6 months. In all, 100 (20.2%) participants left the shelter prematurely and did not continue with methadone. A total of 126 (25.5%) participants continued to stay in the shelters and received methadone for 6 months, with 125 (25.3%) participants leaving the shelter with continued follow-up at a COSUP site. CONCLUSION : This study demonstrates variability in methadone dosing regimens among shelter residents. As the lockdown measures eased, many chose to leave the shelters, while others remained to receive methadone and other services. The COSUP appears to be effective during periods of increased vulnerability, since a large number of participants were successfully followed up. CONTRIBUTION : Opioid dependence is a persistent, lifelong disease. It is multifaceted with complex environmental and individual determinants. This study highlighted the use of opioid substitution therapy during a period of increased vulnerability.en_US
dc.description.departmentFamily Medicineen_US
dc.description.sdgNoneen_US
dc.description.urihttps://www.safpj.co.zaen_US
dc.identifier.citationSiemens, J.-M.A., Bhoora, U. & Janse van Rensburg, M. Methadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdown. South African Family Practice 2023;65(1), a5708. https://DOI.org/10.4102/safp.v65i1.5708.en_US
dc.identifier.issn2078-6190 (print)
dc.identifier.issn2078-6204 (online)
dc.identifier.other10.4102/safp. v65i1.5708
dc.identifier.urihttp://hdl.handle.net/2263/94689
dc.language.isoenen_US
dc.publisherAOSISen_US
dc.rights© 2023. The Authors Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.en_US
dc.subjectSubstance useen_US
dc.subjectOpioid dependenceen_US
dc.subjectAdherenceen_US
dc.subjectMethadoneen_US
dc.subjectHomeless sheltersen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCommunity oriented substance use programme (COSUP)en_US
dc.subject.otherHealth sciences articles SDG-03
dc.subject.otherSDG-03: Good health and well-being
dc.subject.otherHealth sciences articles SDG-11
dc.subject.otherSDG-11: Sustainable cities and communities
dc.titleMethadone use for acute opioid withdrawal in Tshwane shelters during the COVID-19 lockdownen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Siemens_Methadone_2023.pdf
Size:
953.17 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: